New Enterprise Associates 14, L.P.

Insider profile

Performance

Overall performance
2.4

Performance over holding periods
4.2
30 days 90 days 120 days
Average return -2% 8.2% 15.1%
Success rate 35% 68% 82%
Transactions
23 4% Buy
34 71% Buy
47 69% Buy
Performance for realised trades
4.4
Average return -89%
Success rate 73%
Average holding period 220
Transactions 28
New Enterprise Associates 14, L.P.'s trades of Adaptimmune Therapeutics PLC's stock


Loading...
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
406.22
Quantity 37,014
Value US$3,497,120
Transaction date
Proposed sale
Price
344.49
Quantity 24,554
Value US$1,444,122
Transaction date
Proposed sale
Price
47.07
Quantity 99,163
Value US$1,705,591
Transaction date
Proposed sale
Price
1.64
Quantity 4,539,242
Value US$7,448,896
Transaction date
Sale
Price
3.66
Quantity 420,000 -12.7%
Value US$1,535,562
Transaction date
Purchase
Price
12.00
Quantity 1,250,000 +25.1%
Value US$15,000,000
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2025-08-15 2025-08-15 PrS Proposed sale
37,014
406.22
US$3,497,120
37,014 406.22 US$3,497,120
2025-08-15 2025-08-15 PrS Proposed sale
24,554
344.49
US$1,444,122
24,554 344.49 US$1,444,122
2024-07-17 2024-07-17 PrS Proposed sale
99,163
47.07
US$1,705,591
99,163 47.07 US$1,705,591
2024-04-19 2024-04-19 PrS Proposed sale
4,539,242
1.64
US$7,448,896
4,539,242 1.64 US$7,448,896
2022-04-07 2022-04-06 S Sale
255,463 -8.9%
1.10
US$281,827
255,463 -8.9% 1.10 US$281,827
2022-04-07 2022-04-05 S Sale
439,088 -13.3%
1.07
US$469,429
439,088 -13.3% 1.07 US$469,429
2022-01-25 2022-01-25 S Sale
102,952 -3.0%
1.47
US$151,803
102,952 -3.0% 1.47 US$151,803
2022-01-25 2022-01-24 S Sale
19,984 -0.6%
1.55
US$31,017
19,984 -0.6% 1.55 US$31,017
2022-01-25 2022-01-21 S Sale
11,622 -0.3%
1.67
US$19,389
11,622 -0.3% 1.67 US$19,389
2022-01-20 2022-01-20 S Sale
6,295 -0.2%
1.81
US$11,385
6,295 -0.2% 1.81 US$11,385
2022-01-20 2022-01-19 S Sale
13,412 -0.4%
1.82
US$24,414
13,412 -0.4% 1.82 US$24,414
2022-01-20 2022-01-18 S Sale
6,848 -0.2%
1.89
US$12,927
6,848 -0.2% 1.89 US$12,927
2022-01-14 2022-01-14 S Sale
9,707 -0.3%
1.91
US$18,583
9,707 -0.3% 1.91 US$18,583
2022-01-14 2022-01-13 S Sale
7,209 -0.2%
1.93
US$13,886
7,209 -0.2% 1.93 US$13,886
2022-01-14 2022-01-12 S Sale
4,634 -0.1%
2.02
US$9,357
4,634 -0.1% 2.02 US$9,357
2022-01-11 2022-01-11 S Sale
2,409 -0.1%
2.04
US$4,919
2,409 -0.1% 2.04 US$4,919
2022-01-11 2022-01-10 S Sale
1,751 -0.1%
2.00
US$3,502
1,751 -0.1% 2.00 US$3,502
2022-01-11 2022-01-07 S Sale
14,600 -0.4%
2.08
US$30,318
14,600 -0.4% 2.08 US$30,318
2022-01-06 2022-01-06 S Sale
10,257 -0.3%
2.16
US$22,205
10,257 -0.3% 2.16 US$22,205
2022-01-06 2022-01-05 S Sale
8,200 -0.2%
2.25
US$18,439
8,200 -0.2% 2.25 US$18,439
2022-01-06 2022-01-04 S Sale
13,459 -0.4%
2.34
US$31,544
13,459 -0.4% 2.34 US$31,544
2022-01-03 2022-01-03 S Sale
44,665 -1.2%
2.34
US$104,396
44,665 -1.2% 2.34 US$104,396
2022-01-03 2021-12-31 S Sale
49,953 -1.4%
2.25
US$112,409
49,953 -1.4% 2.25 US$112,409
2022-01-03 2021-12-30 S Sale
21,858 -0.6%
2.29
US$50,066
21,858 -0.6% 2.29 US$50,066
2020-05-22 2020-05-20 S Sale
420,000 -12.7%
3.66
US$1,535,562
420,000 -12.7% 3.66 US$1,535,562
2020-03-16 2020-03-16 B Purchase
475,000 +13.4%
16.00
US$7,600,000
475,000 +13.4% 16.00 US$7,600,000
2020-03-10 2020-03-06 S Sale
708,155 -29.2%
6.99
US$4,950,003
708,155 -29.2% 6.99 US$4,950,003
2020-02-12 2020-02-10 B Purchase
1,250,000 +25.1%
12.00
US$15,000,000
1,250,000 +25.1% 12.00 US$15,000,000
2020-04-13 2019-08-28 S Sale
1,211 -0.0%
2.91
US$3,524
1,211 -0.0% 2.91 US$3,524
2019-03-06 2019-03-05 B Purchase
3,750,000 +46.1%
4.00
US$15,000,000
3,750,000 +46.1% 4.00 US$15,000,000